This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Carlo Confalonier: Inventor of a Ready-to-Use Doxorubicin Solution.
Introduction
Carlo Confalonier is an inventor associated with Milan, Italy, and Pharmacia & Upjohn Company. His recorded patent concerns a stable, ready-to-use injectable formulation of doxorubicin, an antitumor anthracycline glycoside.
Latest Patents
Confalonier is credited with 1 patent: “Injectable Ready-to-Use Solutions Containing an Antitumor Anthracycline Glycoside.” The patent describes a sealed glass container holding a sterile, pyrogen-free doxorubicin solution. The solution is not reconstituted from a lyophilizate and has a pH of 2.5–3.5, with a doxorubicin concentration of 0.1–100 mg/ml. Its formulation uses a physiologically acceptable doxorubicin salt dissolved in a physiologically acceptable solvent.
Career Highlights
The patent reflects work on preparing doxorubicin in a stable injectable form that is ready for use, rather than requiring reconstitution from a freeze-dried product. Confalonier’s listed company affiliation is Pharmacia & Upjohn Company.
Collaborations
His listed coworkers include Gaetano Gatti and Diego Oldani. The available information identifies them as coworkers but does not specify their roles in the patent.
Conclusion
Carlo Confalonier’s recorded invention focuses on a ready-to-use injectable doxorubicin solution, highlighting his contribution to pharmaceutical formulation innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile